InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, today announced that the first subject has been dosed in ...

A new study reveals that changes in gut microbial load, influenced by factors like diet, age, and antibiotics, drive the presence of bacteria previously linked to diseases such as inflammatory bowel ...

Scientists at UMC Utrecht have developed a new technology to efficiently isolate a specific subset of gut bacteria from fecal ...

CNN adds that straining while on the toilet has its downsides as well. Forcing a bowel movement creates a risk for ...

P13, a biosimilar of infliximab, in inflammatory bowel diseases: a systematic review and meta-analysis," published in the November 2024 issue of Gastroenterology by Hu et al. Since 2015, CT-P13, a ...

Abivax presents third quarter 2024 key financial information PARIS, France, November 14, 2024, 10:00 p.m. CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq – ABVX) (“Abivax” or the ...

Linda Winston decided after over two decades being a patient dealing with Crohn’s disease, she wanted to become an advocate ...

Experts advise limiting toilet time to 10 minutes to avoid health risks like hemorrhoids and weakened pelvic muscles.

Santo Domingo.- Médico Express has launched a state-of-the-art Gastroenterology Unit, led by renowned specialist Dr. Rosa U.

Thetis Pharmaceuticals, LLC ("Thetis"), a pharmaceutical company developing an oral, small molecule Resolvin E1 (RvE1) drug targeting the BLT1 receptor to treat inflammatory bowel disease (IBD) and ...

One woman’s journey from receiving her diagnosis to finding a treatment that helps manage her chronic skin condition.

Abivax presents third quarter 2024 key financial information. PARIS, France, November 14, 2024, 10:00 p.m. CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq – AB ...